|Articles|June 1, 2017
- BioPharm International-06-01-2017
- Volume 30
- Issue 6
BioPharm International, June 2017 Issue (PDF)
Click the title above to open the BioPharm International June 2017 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 8 years ago
Troubleshooting Lab Operations: Be Proactive, Not Reactiveover 8 years ago
Unifying Continuous Biomanufacturing Operationsover 8 years ago
N-Glycan Analysis of Biotherapeutic Proteinsover 8 years ago
Ensure Quality in a Contract Test Laboratoryover 8 years ago
Storing and Shipping Frozen APIs in Single-Use Containersover 8 years ago
Drug Spending Not Driving Rising Healthcare Costsover 8 years ago
Managing Residual Impurities During Downstream Processingover 8 years ago
A Novel Metric for Continuous Improvement During Stage ThreeNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Year in Review: How FDA Guidances Defined the 2025 Biopharma Landscape
2
Ultragenyx Phase III Data Reveal Limits of Bone Density Endpoints in Rare Bone Disease
3
Building Robust Biomanufacturing Networks for the Next Wave of Therapies
4
Biopharma’s 2025 Transformation: A Recap of Our Top 10 Articles
5
